相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia
Yoshiaki Nishimura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity
Julia Niessl et al.
NATURE MEDICINE (2020)
The V2 loop of HIV gp120 delivers costimulatory signals to CD4+ T cells through Integrin α4β7 and promotes cellular activation and infection
Livia R. Goes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
Marina Caskey et al.
NATURE MEDICINE (2019)
Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques
Giulia Calenda et al.
PLOS PATHOGENS (2019)
Lack of therapeutic efficacy of an antibody to α4β7 SIVmac251-infected rhesus macaques
Peter Abbink et al.
SCIENCE (2019)
Evaluation of an antibody to α4β7 in the control of SIVmac239-nef-stop infection
M. Di Mascio et al.
SCIENCE (2019)
Blocling α4β7 integrin binding to SIV does not improve virologic control
Nami Iwamoto et al.
SCIENCE (2019)
Accurate Prediction for Antibody Resistance of Clinical HIV-1 Isolates
Reda Rawi et al.
SCIENTIFIC REPORTS (2019)
Integrin α4β7 Blockade Preferentially Impacts CCR6+ Lymphocyte Subsets in Blood and Mucosal Tissues of Naive Rhesus Macaques
Giulia Calenda et al.
JOURNAL OF IMMUNOLOGY (2018)
The ethical justification for the use of non-human primates in research: the Weatherall report revisited
Gardar Arnason
JOURNAL OF MEDICAL ETHICS (2018)
Early treatment of SIV plus macaques with an α4β7 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection
P. J. Santangelo et al.
MUCOSAL IMMUNOLOGY (2018)
MAdCAM costimulation through Integrin-α4β7 promotes HIV replication
Fatima Nawaz et al.
MUCOSAL IMMUNOLOGY (2018)
Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes
Aida Sivro et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Pilar Mendoza et al.
NATURE (2018)
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
Yotam Bar-On et al.
NATURE MEDICINE (2018)
Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo
Nina Derby et al.
NATURE COMMUNICATIONS (2018)
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
Erica N. Borducchi et al.
NATURE (2018)
Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals
Mathieu Uzzan et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys
Boris Julg et al.
JOURNAL OF VIROLOGY (2017)
Early antibody therapy can induce long-lasting immunity to SHIV
Yoshiaki Nishimura et al.
NATURE (2017)
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
Marina Caskey et al.
NATURE MEDICINE (2017)
Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health?
Joseph A. McBride et al.
PLOS PATHOGENS (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
Johannes F. Scheid et al.
NATURE (2016)
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
K. J. Bar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Rectal HSV-2 Infection May Increase Rectal SIV Acquisition Even in the Context of SIVΔnef Vaccination
Natalia Guerra-Perez et al.
PLOS ONE (2016)
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
Till Schoofs et al.
SCIENCE (2016)
Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy (Publication with Expression of Concern. See vol. 365, pg. 991, 2019)
Siddappa N. Byrareddy et al.
SCIENCE (2016)
A Small Molecule, Which Competes with MAdCAM-1, Activates Integrin α4β7 and Fails to Prevent Mucosal Transmission of SHIV-SF162P3
Geraldine Arrode-Bruses et al.
PLOS PATHOGENS (2016)
PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo
Meropi Aravantinou et al.
PLOS ONE (2016)
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Marina Caskey et al.
NATURE (2015)
Whole-body immuno PET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques
Philip J. Santangelo et al.
NATURE METHODS (2015)
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M. Lynch et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Analysis of immunoglobulin transcripts and hypermutation following SHIVAD8 infection and protein-plus-adjuvant immunization
Joseph R. Francica et al.
NATURE COMMUNICATIONS (2015)
Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo
Rebecca S. Rudicell et al.
JOURNAL OF VIROLOGY (2014)
Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection
Siddappa N. Byrareddy et al.
NATURE MEDICINE (2014)
Transplanting Supersites of HIV-1 Vulnerability
Tongqing Zhou et al.
PLOS ONE (2014)
Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody
Thomas W. Geisbert et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
A treatment for and vaccine against the deadly Hendra and Nipah viruses
Christopher C. Broder et al.
ANTIVIRAL RESEARCH (2013)
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
Masashi Shingai et al.
NATURE (2013)
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
Dan H. Barouch et al.
NATURE (2013)
Blocking of α4β7 Gut-Homing Integrin during Acute Infection Leads to Decreased Plasma and Gastrointestinal Tissue Viral Loads in Simian Immunodeficiency Virus-Infected Rhesus Macaques
Aftab A. Ansari et al.
JOURNAL OF IMMUNOLOGY (2011)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Robert Pejchal et al.
SCIENCE (2011)
HSV-2 Infection of Dendritic Cells Amplifies a Highly Susceptible HIV-1 Cell Target
Elena Martinelli et al.
PLOS PATHOGENS (2011)
Therapeutic targeting of respiratory syncytial virus G-protein
Lawrence M. Kauvar et al.
IMMUNOTHERAPY (2010)
A Crucial Role for Infected-Cell/Antibody Immune Complexes in the Enhancement of Endogenous Antiviral Immunity by Short Passive Immunotherapy
Henri-Alexandre Michaud et al.
PLOS PATHOGENS (2010)
Preliminary in vivo efficacy studies of a recombinant rhesus anti-alpha(4)beta(7) monoclonal antibody
L. E. Pereira et al.
CELLULAR IMMUNOLOGY (2009)
Endogenous cytotoxic T-Cell response contributes to the long-term antiretroviral protection induced by a short period of antibody-based immunotherapy of neonatally infected mice
Laurent Gros et al.
JOURNAL OF VIROLOGY (2008)
Post-Infection Immunodeficiency Virus Control by Neutralizing Antibodies
Hiroyuki Yamamoto et al.
PLOS ONE (2007)
Induction of long-term protective antiviral endogenous immune response by short neutralizing monoclonal antibody treatment
L Gros et al.
JOURNAL OF VIROLOGY (2005)
Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies
NL Haigwood et al.
JOURNAL OF VIROLOGY (2004)